3:I[2885,["231","static/chunks/231-9e11bdfe3b664aec.js","669","static/chunks/app/asx/%5Bticker%5D/page-bf9260c50397686f.js"],"default"]
4:I[231,["231","static/chunks/231-9e11bdfe3b664aec.js","669","static/chunks/app/asx/%5Bticker%5D/page-bf9260c50397686f.js"],""]
5:I[9275,[],""]
7:I[1343,[],""]
8:I[8173,["231","static/chunks/231-9e11bdfe3b664aec.js","896","static/chunks/896-78f6f35c40d7ae60.js","185","static/chunks/app/layout-24f8abeacb8025a3.js"],"Image"]
9:I[5864,["231","static/chunks/231-9e11bdfe3b664aec.js","896","static/chunks/896-78f6f35c40d7ae60.js","185","static/chunks/app/layout-24f8abeacb8025a3.js"],"default"]
2:T5ea,{"@context":"https://schema.org","@type":"FAQPage","mainEntity":[{"@type":"Question","name":"What does HCT do?","acceptedAnswer":{"@type":"Answer","text":"Holista Colltech (ASX: HCT) is a biotechnology and wellness company that develops and commercialises low glycaemic index (GI) food ingredients and natural health supplements. They aim to provide healthier food alternatives and natural solutions to combat lifestyle diseases, operating primarily from Malaysia with global market aspirations."}},{"@type":"Question","name":"Is HCT a good investment?","acceptedAnswer":{"@type":"Answer","text":"As a micro-cap company (A$31M) in a competitive sector, HCT is a speculative investment. Opportunities lie in the growing global demand for healthy foods and supplements, and the potential of its patented low-GI technologies. However, risks include intense competition, funding challenges, regulatory complexities, and the need to achieve consistent profitability to validate its business model."}},{"@type":"Question","name":"What drives HCT's share price?","acceptedAnswer":{"@type":"Answer","text":"HCT's share price is primarily driven by progress in commercialising its patented low-GI ingredients, successful expansion of its supplement lines into new markets, the signing of significant distribution or licensing agreements, and its financial performance (revenue growth, pathway to profitability). News regarding clinical trials or regulatory approvals for its products can also be significant catalysts."}}]}6:["ticker","HCT","d"]
0:["3PUrEllT2ZlHfyQIbFEtp",[[["",{"children":["asx",{"children":[["ticker","HCT","d"],{"children":["__PAGE__?{\"ticker\":\"HCT\"}",{}]}]}]},"$undefined","$undefined",true],["",{"children":["asx",{"children":[["ticker","HCT","d"],{"children":["__PAGE__",{},[["$L1",["$","div",null,{"className":"space-y-12","children":[["$","script",null,{"type":"application/ld+json","dangerouslySetInnerHTML":{"__html":"$2"}}],["$","section",null,{"className":"grid gap-8 lg:grid-cols-[1.6fr_0.8fr]","children":[["$","div",null,{"className":"space-y-6","children":[["$","div",null,{"className":"glass-card rounded-2xl p-6","children":[["$","p",null,{"className":"text-xs uppercase tracking-[0.3em] text-blue-300","children":"Consumer Staples"}],["$","h1",null,{"className":"mt-3 font-display text-3xl font-semibold","children":["Holista Colltech Limited"," (","HCT",")"]}],["$","p",null,{"className":"mt-4 text-sm text-slate-300","children":"Holista Colltech Limited (ASX: HCT) is a Malaysian-based, Australian-listed biotechnology and wellness company focused on developing and commercialising innovative health products and low glycaemic index (GI) food ingredients. The company's portfolio includes patented low-GI flour and noodle mixes, natural food additives, and a range of dietary supplements aimed at addressing lifestyle diseases and improving health outcomes globally."}],["$","div",null,{"className":"mt-6 grid gap-4 sm:grid-cols-2","children":[["$","div",null,{"className":"rounded-xl border border-white/10 bg-ink-900/40 p-4","children":[["$","p",null,{"className":"text-xs text-slate-500","children":"Market Cap"}],["$","p",null,{"className":"mt-2 text-lg font-semibold","children":"A$31M"}]]}],["$","div",null,{"className":"rounded-xl border border-white/10 bg-ink-900/40 p-4","children":[["$","p",null,{"className":"text-xs text-slate-500","children":"Shares on Issue"}],["$","p",null,{"className":"mt-2 text-lg font-semibold","children":"N/A"}]]}]]}],["$","div",null,{"className":"mt-6 flex flex-wrap gap-3 text-xs text-slate-400","children":[["$","a",null,{"href":"","className":"rounded-full border border-white/10 px-3 py-1","children":"Company Website"}],["$","span",null,{"className":"rounded-full border border-white/10 px-3 py-1","children":"AI coverage updated hourly"}],["$","span",null,{"className":"rounded-full border border-white/10 px-3 py-1","children":"Data from ASX filings"}]]}]]}],["$","$L3",null,{"ticker":"HCT"}],["$","section",null,{"className":"space-y-6","children":[["$","div",null,{"className":"glass-card rounded-2xl p-6","children":[["$","h2",null,{"className":"font-display text-xl font-semibold","children":"AI Analysis"}],["$","div",null,{"className":"mt-4 space-y-4 text-sm text-slate-300","children":[["$","p","Holista Colltech is a micro-cap player in the health and wellness sector, positioned with proprietary low-GI technologies and natural supplement formulations. Its current business heavily relies on the commercialisation and market penetration of its patented food ingredients, particularly in Asia, alongside the growth of its branded supplement lines. As a smaller entity, HCT has historically faced challenges in scaling production and achieving consistent profitability, often operating with modest revenues relative to its market cap, reflecting the early-to-mid stage of its product lifecycle.",{"children":"Holista Colltech is a micro-cap player in the health and wellness sector, positioned with proprietary low-GI technologies and natural supplement formulations. Its current business heavily relies on the commercialisation and market penetration of its patented food ingredients, particularly in Asia, alongside the growth of its branded supplement lines. As a smaller entity, HCT has historically faced challenges in scaling production and achieving consistent profitability, often operating with modest revenues relative to its market cap, reflecting the early-to-mid stage of its product lifecycle."}],["$","p","The growth outlook for HCT is tied to increasing health consciousness and demand for low-GI foods and natural supplements, particularly in emerging markets. Upcoming catalysts could include new distribution agreements, successful product launches into new geographic markets, regulatory approvals for new ingredients or claims, and positive clinical studies demonstrating the efficacy of its products. Strategically, HCT aims to expand its global footprint through partnerships and licensing agreements, leveraging its R&D capabilities to innovate within the rapidly evolving nutraceutical and healthy food ingredient landscape.",{"children":"The growth outlook for HCT is tied to increasing health consciousness and demand for low-GI foods and natural supplements, particularly in emerging markets. Upcoming catalysts could include new distribution agreements, successful product launches into new geographic markets, regulatory approvals for new ingredients or claims, and positive clinical studies demonstrating the efficacy of its products. Strategically, HCT aims to expand its global footprint through partnerships and licensing agreements, leveraging its R&D capabilities to innovate within the rapidly evolving nutraceutical and healthy food ingredient landscape."}]]}]]}],["$","div",null,{"className":"grid gap-6 lg:grid-cols-2","children":[["$","div",null,{"className":"glass-card rounded-2xl p-6","children":[["$","h3",null,{"className":"flex items-center gap-2 text-sm font-semibold text-emerald-300","children":"Bull Case"}],["$","ul",null,{"className":"mt-4 space-y-2 text-sm text-slate-300","children":[["$","li","Successful commercialisation and widespread adoption of its patented low-GI ingredients, leading to significant revenue growth through new supply contracts with food manufacturers.",{"children":["â€¢ ","Successful commercialisation and widespread adoption of its patented low-GI ingredients, leading to significant revenue growth through new supply contracts with food manufacturers."]}],["$","li","Expansion into new international markets for its dietary supplements and health products, particularly in regions with high demand for natural wellness solutions and lifestyle disease management.",{"children":["â€¢ ","Expansion into new international markets for its dietary supplements and health products, particularly in regions with high demand for natural wellness solutions and lifestyle disease management."]}],["$","li","Strategic partnerships or licensing agreements with larger food or pharmaceutical companies, providing capital infusion, enhanced distribution, and validation of HCT's intellectual property.",{"children":["â€¢ ","Strategic partnerships or licensing agreements with larger food or pharmaceutical companies, providing capital infusion, enhanced distribution, and validation of HCT's intellectual property."]}]]}]]}],["$","div",null,{"className":"glass-card rounded-2xl p-6","children":[["$","h3",null,{"className":"flex items-center gap-2 text-sm font-semibold text-red-300","children":"Bear Case"}],["$","ul",null,{"className":"mt-4 space-y-2 text-sm text-slate-300","children":[["$","li","Intense competition from established players in the healthy food and supplement markets, potentially limiting HCT's market share and pricing power.",{"children":["â€¢ ","Intense competition from established players in the healthy food and supplement markets, potentially limiting HCT's market share and pricing power."]}],["$","li","Regulatory hurdles or changes in health claims standards in key markets, which could impact product approvals or marketing strategies and incur significant compliance costs.",{"children":["â€¢ ","Regulatory hurdles or changes in health claims standards in key markets, which could impact product approvals or marketing strategies and incur significant compliance costs."]}],["$","li","Challenges in securing adequate funding for continued research, development, and market expansion as a micro-cap company, potentially leading to significant shareholder dilution or operational slowdowns.",{"children":["â€¢ ","Challenges in securing adequate funding for continued research, development, and market expansion as a micro-cap company, potentially leading to significant shareholder dilution or operational slowdowns."]}]]}]]}]]}]]}],null,["$","div",null,{"className":"glass-card rounded-2xl p-6","children":[["$","h3",null,{"className":"font-display text-lg font-semibold","children":"Recent Announcements"}],["$","div",null,{"className":"mt-4 space-y-3 text-sm text-slate-300","children":[["$","div","0",{"className":"rounded-xl border border-white/10 bg-ink-900/40 p-4","children":[["$","div",null,{"className":"flex flex-wrap items-center gap-2","children":[["$","p",null,{"className":"font-semibold text-white","children":"Quarterly Activity and Cashflow Report"}],["$","span",null,{"className":"inline-flex items-center gap-1 rounded-full border border-red-500/30 bg-red-500/10 px-2 py-0.5 text-[10px] font-semibold uppercase tracking-wider text-red-400","title":"Price sensitive","children":"ðŸš¨ Price Sensitive"}]]}],["$","div",null,{"className":"mt-1 flex flex-wrap items-center gap-3 text-xs text-slate-500","children":[["$","span",null,{"children":"29 Jan 2026"}],["$","span",null,{"className":"rounded-full border border-white/10 bg-ink-800 px-2 py-0.5","children":"Quarterly Report"}]]}],["$","p",null,{"className":"mt-2 text-xs text-slate-400","children":"HCT, a commitments test entity on ASX, has released its quarterly activity report detailing financial performance and cash flow for investors to review."}]]}]]}]]}],["$","div",null,{"className":"glass-card rounded-2xl p-6","children":[["$","h3",null,{"className":"font-display text-lg font-semibold","children":"FAQs"}],["$","div",null,{"className":"mt-4 space-y-3 text-sm text-slate-300","children":[["$","div","What does HCT do?",{"className":"border-b border-white/5 pb-3","children":[["$","p",null,{"className":"font-semibold text-white","children":"What does HCT do?"}],["$","p",null,{"className":"text-slate-400","children":"Holista Colltech (ASX: HCT) is a biotechnology and wellness company that develops and commercialises low glycaemic index (GI) food ingredients and natural health supplements. They aim to provide healthier food alternatives and natural solutions to combat lifestyle diseases, operating primarily from Malaysia with global market aspirations."}]]}],["$","div","Is HCT a good investment?",{"className":"border-b border-white/5 pb-3","children":[["$","p",null,{"className":"font-semibold text-white","children":"Is HCT a good investment?"}],["$","p",null,{"className":"text-slate-400","children":"As a micro-cap company (A$31M) in a competitive sector, HCT is a speculative investment. Opportunities lie in the growing global demand for healthy foods and supplements, and the potential of its patented low-GI technologies. However, risks include intense competition, funding challenges, regulatory complexities, and the need to achieve consistent profitability to validate its business model."}]]}],["$","div","What drives HCT's share price?",{"className":"border-b border-white/5 pb-3","children":[["$","p",null,{"className":"font-semibold text-white","children":"What drives HCT's share price?"}],["$","p",null,{"className":"text-slate-400","children":"HCT's share price is primarily driven by progress in commercialising its patented low-GI ingredients, successful expansion of its supplement lines into new markets, the signing of significant distribution or licensing agreements, and its financial performance (revenue growth, pathway to profitability). News regarding clinical trials or regulatory approvals for its products can also be significant catalysts."}]]}]]}]]}]]}],["$","div",null,{"className":"space-y-6","children":[["$","div",null,{"className":"glass-card rounded-2xl p-6","children":[["$","h3",null,{"className":"font-semibold","children":"Key Metrics"}],["$","div",null,{"className":"mt-4 space-y-4 text-sm","children":[["$","div",null,{"className":"flex items-center justify-between","children":[["$","span",null,{"className":"text-slate-400","children":"Share Price"}],["$","span",null,{"className":"font-semibold","children":["A$","0.09"]}]]}],["$","div",null,{"className":"flex items-center justify-between","children":[["$","span",null,{"className":"text-slate-400","children":"1Y Performance"}],["$","span",null,{"className":"font-semibold text-emerald-400","children":["174.2","%"]}]]}],["$","div",null,{"className":"flex items-center justify-between","children":[["$","span",null,{"className":"text-slate-400","children":"Market Cap"}],["$","span",null,{"className":"font-semibold","children":"A$31M"}]]}],["$","div",null,{"className":"flex items-center justify-between","children":[["$","span",null,{"className":"text-slate-400","children":"Shares on Issue"}],["$","span",null,{"className":"font-semibold","children":"N/A"}]]}],["$","div",null,{"className":"flex items-center justify-between","children":[["$","span",null,{"className":"text-slate-400","children":"Sector"}],["$","span",null,{"className":"font-semibold","children":"Consumer Staples"}]]}],["$","div",null,{"className":"flex items-center justify-between","children":[["$","span",null,{"className":"text-slate-400","children":"IPO Date"}],["$","span",null,{"className":"font-semibold","children":"26/02/2004"}]]}]]}]]}],["$","div",null,{"className":"glass-card rounded-2xl p-6","children":[["$","h3",null,{"className":"font-display text-lg font-semibold","children":"Related Stocks"}],["$","div",null,{"className":"mt-4 space-y-4","children":[["$","$L4",null,{"href":"/asx/A2M","className":"group rounded-2xl border border-white/10 bg-ink-900/80 p-5 transition hover:-translate-y-1 hover:border-blue-500/40","children":[["$","div",null,{"className":"flex items-center justify-between","children":[["$","div",null,{"children":[["$","p",null,{"className":"text-xs uppercase tracking-[0.2em] text-slate-500","children":"Consumer Staples"}],["$","h3",null,{"className":"mt-2 font-display text-lg font-semibold","children":["A2M",["$","span",null,{"className":"ml-2 text-sm text-slate-400","children":"The A2 Milk Company Limited"}]]}]]}],["$","div",null,{"className":"text-right","children":[["$","p",null,{"className":"text-sm text-slate-300","children":["A$","8.53"]}],["$","p",null,{"className":"text-xs font-semibold text-emerald-400","children":["7.6","% 1Y"]}]]}]]}],["$","p",null,{"className":"mt-4 text-sm text-slate-400","children":"The A2 Milk Company Limited operates in the consumer staples sector, focusing on milk and related products. It develops, markets, and distributes A2 dairy products, primarily in New Zealand, Australia, China, and the United States. Key products include A2 Ultra millions, A2 Organic milk, and infant formula."}],["$","div",null,{"className":"mt-4 flex items-center justify-between text-xs text-slate-500","children":[["$","span",null,{"children":["Market cap ","A$6.2B"]}],["$","span",null,{"className":"text-blue-300","children":"View analysis"}]]}]]}],["$","$L4",null,{"href":"/asx/AAC","className":"group rounded-2xl border border-white/10 bg-ink-900/80 p-5 transition hover:-translate-y-1 hover:border-blue-500/40","children":[["$","div",null,{"className":"flex items-center justify-between","children":[["$","div",null,{"children":[["$","p",null,{"className":"text-xs uppercase tracking-[0.2em] text-slate-500","children":"Consumer Staples"}],["$","h3",null,{"className":"mt-2 font-display text-lg font-semibold","children":["AAC",["$","span",null,{"className":"ml-2 text-sm text-slate-400","children":"Australian Agricultural Company Limited."}]]}]]}],["$","div",null,{"className":"text-right","children":[["$","p",null,{"className":"text-sm text-slate-300","children":["A$","1.33"]}],["$","p",null,{"className":"text-xs font-semibold text-red-400","children":["-8.3","% 1Y"]}]]}]]}],["$","p",null,{"className":"mt-4 text-sm text-slate-400","children":"Australian Agricultural Company (AAC) is one of Australia's largest beef producers and landholders, primarily focused on breeding, raising, and marketing Wagyu and other premium beef brands. Operating vast cattle stations across Northern Australia, the company manages the full supply chain from pasture to plate, including properties, cattle, and feedlots. Its key products include high-quality Wagyu beef sold globally under brands like Master Kobe and Wylarah."}],["$","div",null,{"className":"mt-4 flex items-center justify-between text-xs text-slate-500","children":[["$","span",null,{"children":["Market cap ","A$805M"]}],["$","span",null,{"className":"text-blue-300","children":"View analysis"}]]}]]}],["$","$L4",null,{"href":"/asx/AAP","className":"group rounded-2xl border border-white/10 bg-ink-900/80 p-5 transition hover:-translate-y-1 hover:border-blue-500/40","children":[["$","div",null,{"className":"flex items-center justify-between","children":[["$","div",null,{"children":[["$","p",null,{"className":"text-xs uppercase tracking-[0.2em] text-slate-500","children":"Consumer Staples"}],["$","h3",null,{"className":"mt-2 font-display text-lg font-semibold","children":["AAP",["$","span",null,{"className":"ml-2 text-sm text-slate-400","children":"Australian Agricultural Projects Limited"}]]}]]}],["$","div",null,{"className":"text-right","children":[["$","p",null,{"className":"text-sm text-slate-300","children":["A$","0.05"]}],["$","p",null,{"className":"text-xs font-semibold text-emerald-400","children":["6.8","% 1Y"]}]]}]]}],["$","p",null,{"className":"mt-4 text-sm text-slate-400","children":"Australian Agricultural Projects Ltd is an agribusiness company focused on the management and operation of olive groves in Victoria, Australia. The company's primary activities involve the harvesting and processing of olives to produce premium extra virgin olive oil for both domestic and international markets. Additionally, AAP provides horticultural management and consulting services for its own and third-party agricultural assets."}],["$","div",null,{"className":"mt-4 flex items-center justify-between text-xs text-slate-500","children":[["$","span",null,{"children":["Market cap ","A$17M"]}],["$","span",null,{"className":"text-blue-300","children":"View analysis"}]]}]]}]]}]]}]]}]]}]]}]],null],null]},["$","$L5",null,{"parallelRouterKey":"children","segmentPath":["children","asx","children","$6","children"],"error":"$undefined","errorStyles":"$undefined","errorScripts":"$undefined","template":["$","$L7",null,{}],"templateStyles":"$undefined","templateScripts":"$undefined","notFound":"$undefined","notFoundStyles":"$undefined","styles":null}],null]},["$","$L5",null,{"parallelRouterKey":"children","segmentPath":["children","asx","children"],"error":"$undefined","errorStyles":"$undefined","errorScripts":"$undefined","template":["$","$L7",null,{}],"templateStyles":"$undefined","templateScripts":"$undefined","notFound":"$undefined","notFoundStyles":"$undefined","styles":null}],null]},[["$","html",null,{"lang":"en","className":"__variable_6d343d __variable_49a339","children":[["$","head",null,{"children":["$","link",null,{"rel":"icon","href":"/logo.svg","type":"image/svg+xml"}]}],["$","body",null,{"className":"min-h-screen bg-ink-900 text-slate-100","children":["$","div",null,{"className":"min-h-screen","children":[["$","header",null,{"className":"sticky top-0 z-50 border-b border-white/10 bg-ink-800/80 backdrop-blur","children":[["$","div",null,{"className":"mx-auto flex w-full max-w-6xl items-center justify-between px-4 py-4 sm:px-6 lg:px-8","children":[["$","$L4",null,{"href":"/","className":"flex items-center gap-3","children":[["$","$L8",null,{"src":"/logo.svg","alt":"ASX Desk","width":140,"height":40,"className":"h-10 w-auto","priority":true}],["$","span",null,{"className":"hidden text-xs uppercase tracking-[0.2em] text-slate-400 sm:inline","children":"Research Terminal"}]]}],["$","nav",null,{"className":"hidden items-center gap-6 text-sm text-slate-300 md:flex","children":[["$","$L4","/",{"href":"/","className":"transition hover:text-white","children":"Home"}],["$","$L4","/screener",{"href":"/screener","className":"transition hover:text-white","children":"Screener"}],["$","$L4","/sectors/materials",{"href":"/sectors/materials","className":"transition hover:text-white","children":"Sectors"}],["$","$L4","/news",{"href":"/news","className":"transition hover:text-white","children":"News"}],["$","$L4","/compare/BHP-vs-RIO",{"href":"/compare/BHP-vs-RIO","className":"transition hover:text-white","children":"Compare"}],["$","$L4","/about",{"href":"/about","className":"transition hover:text-white","children":"About"}]]}],["$","div",null,{"className":"hidden items-center gap-3 md:flex","children":[["$","$L9",null,{}],["$","button",null,{"className":"rounded-full border border-blue-500/40 px-4 py-2 text-xs font-semibold uppercase tracking-wide text-blue-200 shadow-glow transition hover:bg-blue-500/20","children":"Premium Research"}],["$","button",null,{"className":"rounded-full bg-blue-500 px-4 py-2 text-xs font-semibold uppercase tracking-wide text-white shadow-glow transition hover:bg-blue-400","children":"Open Account"}]]}]]}],["$","div",null,{"className":"flex items-center justify-between gap-3 border-t border-white/5 px-4 py-3 md:hidden","children":[["$","div",null,{"className":"flex-1","children":["$","$L9",null,{}]}],["$","$L4",null,{"href":"/screener","className":"shrink-0 text-xs text-blue-300","children":"Screener"}]]}]]}],["$","main",null,{"className":"mx-auto w-full max-w-6xl px-4 pb-20 pt-6 sm:px-6 lg:px-8","children":["$","$L5",null,{"parallelRouterKey":"children","segmentPath":["children"],"error":"$undefined","errorStyles":"$undefined","errorScripts":"$undefined","template":["$","$L7",null,{}],"templateStyles":"$undefined","templateScripts":"$undefined","notFound":["$","div",null,{"className":"flex min-h-[60vh] flex-col items-center justify-center text-center","children":[["$","p",null,{"className":"text-xs uppercase tracking-[0.3em] text-blue-300","children":"404"}],["$","h1",null,{"className":"mt-3 font-display text-3xl font-semibold","children":"Page not found"}],["$","p",null,{"className":"mt-3 text-sm text-slate-400","children":"We couldn't locate that ASX page. Try searching a ticker or visit the homepage."}],["$","$L4",null,{"href":"/","className":"mt-6 rounded-full bg-blue-500 px-6 py-3 text-xs font-semibold uppercase tracking-wide text-white","children":"Back to Home"}]]}],"notFoundStyles":[],"styles":null}]}],["$","footer",null,{"className":"border-t border-white/10 bg-ink-800/60","children":[["$","div",null,{"className":"mx-auto grid w-full max-w-6xl gap-8 px-4 py-12 sm:px-6 lg:grid-cols-3 lg:px-8","children":[["$","div",null,{"children":[["$","h3",null,{"className":"font-display text-lg font-semibold","children":"ASX Desk"}],["$","p",null,{"className":"mt-3 text-sm text-slate-400","children":"Automated ASX stock research with AI-generated analysis, sector trends, and data-backed screening tools."}],["$","div",null,{"className":"mt-4 flex gap-3","children":[["$","button",null,{"className":"rounded-full bg-blue-500 px-4 py-2 text-xs font-semibold uppercase tracking-wide text-white","children":"Open an Account"}],["$","button",null,{"className":"rounded-full border border-white/10 px-4 py-2 text-xs font-semibold uppercase tracking-wide text-slate-300","children":"Download Media Kit"}]]}]]}],["$","div",null,{"className":"grid grid-cols-2 gap-6 text-sm text-slate-400","children":[["$","div",null,{"children":[["$","h4",null,{"className":"mb-2 font-semibold text-slate-200","children":"Platform"}],["$","ul",null,{"className":"space-y-2","children":[["$","li",null,{"children":["$","$L4",null,{"href":"/screener","className":"hover:text-white","children":"Screener"}]}],["$","li",null,{"children":["$","$L4",null,{"href":"/news","className":"hover:text-white","children":"News & Commentary"}]}],["$","li",null,{"children":["$","$L4",null,{"href":"/about","className":"hover:text-white","children":"About"}]}]]}]]}],["$","div",null,{"children":[["$","h4",null,{"className":"mb-2 font-semibold text-slate-200","children":"Sectors"}],["$","ul",null,{"className":"space-y-2","children":[["$","li",null,{"children":["$","$L4",null,{"href":"/sectors/materials","className":"hover:text-white","children":"Materials"}]}],["$","li",null,{"children":["$","$L4",null,{"href":"/sectors/financials","className":"hover:text-white","children":"Financials"}]}],["$","li",null,{"children":["$","$L4",null,{"href":"/sectors/health care","className":"hover:text-white","children":"Health Care"}]}],["$","li",null,{"children":["$","$L4",null,{"href":"/sectors/information technology","className":"hover:text-white","children":"Information Tech"}]}],["$","li",null,{"children":["$","$L4",null,{"href":"/sectors/energy","className":"hover:text-white","children":"Energy"}]}]]}]]}]]}],["$","div",null,{"className":"glass-card rounded-2xl p-6","children":[["$","h4",null,{"className":"font-semibold","children":"Weekly Alpha Briefing"}],["$","p",null,{"className":"mt-2 text-sm text-slate-400","children":"Get our AI-powered watchlist, sector heatmaps, and new ASX coverage in your inbox."}],["$","div",null,{"className":"mt-4 flex flex-col gap-3 sm:flex-row","children":[["$","input",null,{"type":"email","placeholder":"you@example.com","className":"w-full rounded-full border border-white/10 bg-ink-900/60 px-4 py-2 text-sm text-white placeholder:text-slate-500"}],["$","button",null,{"className":"rounded-full bg-blue-500 px-5 py-2 text-xs font-semibold uppercase tracking-wide text-white","children":"Subscribe"}]]}],["$","p",null,{"className":"mt-3 text-xs text-slate-500","children":"By subscribing you agree to receive marketing updates. Unsubscribe anytime."}]]}]]}],["$","div",null,{"className":"border-t border-white/10 py-6 text-center text-xs text-slate-500","children":["$","p",null,{"children":"General advice only. This site does not consider your objectives, financial situation, or needs. Past performance is not indicative of future results."}]}]]}]]}]}]]}],null],null],[[["$","link","0",{"rel":"stylesheet","href":"/_next/static/css/0c5df3f3122977aa.css","precedence":"next","crossOrigin":"$undefined"}]],[null,"$La"]]]]]
a:[["$","meta","0",{"name":"viewport","content":"width=device-width, initial-scale=1"}],["$","meta","1",{"charSet":"utf-8"}],["$","title","2",{"children":"HCT share price, analysis & company profile - Holista Colltech Limited | ASX Desk"}],["$","meta","3",{"name":"description","content":"Latest HCT share price overview, what Holista Colltech Limited does, bull and bear cases, and AI-powered analysis for ASX investors."}],["$","link","4",{"rel":"canonical","href":"https://asxdesk.com/asx/HCT/"}],["$","meta","5",{"property":"og:title","content":"HCT share price, analysis & company profile - Holista Colltech Limited"}],["$","meta","6",{"property":"og:description","content":"Latest HCT share price overview, what Holista Colltech Limited does, bull and bear cases, and AI-powered analysis for ASX investors."}],["$","meta","7",{"property":"og:url","content":"https://asxdesk.com/asx/HCT/"}],["$","meta","8",{"property":"og:type","content":"article"}],["$","meta","9",{"name":"twitter:card","content":"summary_large_image"}],["$","meta","10",{"name":"twitter:title","content":"HCT share price, analysis & company profile - Holista Colltech Limited"}],["$","meta","11",{"name":"twitter:description","content":"Latest HCT share price overview, what Holista Colltech Limited does, bull and bear cases, and AI-powered analysis for ASX investors."}],["$","meta","12",{"name":"next-size-adjust"}]]
1:null
